Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009RICHTER, Sandra S; HEILMANN, Kristopher P; DOHRN, Cassie L et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 9, pp 4154-4160, issn 0066-4804, 7 p.Article

Prevalence of Serotype 19A Streptococcus pneumoniae among Isolates from U.S. Children in 2005-2006 and Activity of FaropenemCRITCHLEY, Ian A; JACOBS, Michael R; BROWN, Steven D et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 7, pp 2639-2643, issn 0066-4804, 5 p.Article

Susceptibility of Staphylococcus aureus isolated from skin and wound infections in the United States 2005-07 : laboratory-based surveillance studyTILLOTSON, Glenn S; DRAGHI, Deborah C; SAHM, Daniel F et al.Journal of antimicrobial chemotherapy (Print). 2008, Vol 62, Num 1, pp 109-115, issn 0305-7453, 7 p.Article

Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strainsJONES, Ronald N; CRITCHLEY, Ian A; WHITTINGTON, William L. H et al.Diagnostic microbiology and infectious disease. 2005, Vol 53, Num 4, pp 311-317, issn 0732-8893, 7 p.Article

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: Results from the Trust Surveillance Program (1998-2002)KARLOWSKY, James A; THORNSBERRY, Clyde; JONES, Mark E et al.Clinical infectious diseases. 2003, Vol 36, Num 8, pp 963-970, issn 1058-4838, 8 p.Article

National and Regional Assessment of Antimicrobial Resistance among Community-Acquired Respiratory Tract Pathogens Identified in a 2005-2006 U.S. Faropenem Surveillance StudyCRITCHLEY, Ian A; BROWN, Steven D; TRACZEWSKI, Maria M et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 12, pp 4382-4389, issn 0066-4804, 8 p.Article

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaFILE, Thomas M; LOW, Donald E; ECKBURG, Paul B et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, issn 0305-7453, iii19-iii32, SUP3Article

Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and IsraelSTONE, Kimberley Clawson; DAGAN, Ron; ARGUEDAS, Adriano et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 2230-2235, issn 0066-4804, 6 p.Article

Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetaseOCHSNER, Urs A; YOUNG, Casey L; STONE, Kimberley C et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4253-4262, issn 0066-4804, 10 p.Article

Longitudinal assessment of antipneumococcal susceptibility in the United StatesJONES, Mark E; KARLOWSKY, James A; BLOSSER-MIDDLETON, Renée et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 8, pp 2651-2655, issn 0066-4804Article

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S; JONES, Mark E et al.International journal of antimicrobial agents. 2002, Vol 20, Num 2, pp 100-107, issn 0924-8579, 8 p.Article

Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States : 2-year longitudinal analysisSAHM, Daniel F; KARLOWSKY, James A; KELLY, Laurie J et al.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 4, pp 1037-1042, issn 0066-4804Article

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumoniaLOW, Donald E; FILE, Thomas M; ECKBURG, Paul B et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, issn 0305-7453, iii33-iii44, SUP3Article

Antibacterial activity of REP8839, a new antibiotic for topical useCRITCHLEY, Ian A; YOUNG, Casey L; STONE, Kimberley C et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 10, pp 4247-4252, issn 0066-4804, 6 p.Article

Activity of cefditoren against β-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalisKARLOWSKY, James A; CRITCHLEY, Ian A; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 1, pp 53-58, issn 0732-8893Article

Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a β-lactamase-negative and ampicillin-resistant strainKARLOWSKY, James A; CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S et al.Journal of clinical microbiology (Print). 2002, Vol 40, Num 3, pp 1063-1066, issn 0095-1137Article

Determining linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national releaseKARLOWSKY, James A; KELLY, Laurie J; CRITCHLEY, Ian A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1989-1992, issn 0066-4804Article

Regional trends in antimicrobial Resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST surveillance program, 1999-2000THORNSBERRY, Clyde; SAHM, Daniel F; KELLY, Laurie J et al.Clinical infectious diseases. 2002, Vol 34, pp S4-S16, issn 1058-4838, SUP1Article

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Evaluate In Vitro Susceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptococcus pneumoniaeVAN WART, Scott A; AMBROSE, Paul G; RUBINO, Christopher M et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 2, pp 885-891, issn 0066-4804, 7 p.Article

Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infectionsCRITCHLEY, Ian A; GREEN, Louis S; YOUNG, Casey L et al.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 5, pp 954-963, issn 0305-7453, 10 p.Article

Activities of faropenem, an oral β-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisCRITCHLEY, Ian A; KARLOWSKY, James A; DRAGHI, Deborah C et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 2, pp 550-555, issn 0066-4804Article

In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IVJONES, Mark E; CRITCHLEY, Ian A; KARLOWSKY, James A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1651-1657, issn 0066-4804Article

In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditorenKARLOWSKY, James A; JONES, Mark E; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 1, pp 59-64, issn 0732-8893Article

The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000JONES, Mark E; BLOSSER-MIDDLETON, Renee S; CRITCHLEY, Ian A et al.Chemotherapy (Basel). 2002, Vol 48, Num 5, pp 232-237, issn 0009-3157, 6 p.Article